News for Incyte Corporation (ICY.MU)

Vancouver, British Columbia, March 01, 2021 (GLOBE NEWSWIRE) -- The global immunotherapy drugs market is projected to reach value of USD 365.57 Billion by ...

Insider buying can be an encouraging signal for potential investors, especially when markets face uncertainty. Returning buyers and chief executives were ...

  1 Attachments Original document Permalink ... | February 24, 2021

Incyte Corporation (NASDAQ:INCY) has been downgraded to Underperform from Market Perform at SVB Leerink. Explore why.

Incyte Corporation (NASDAQ:INCY) Q4 2020 Earnings Conference Call February 9, 2021 8:00 AM ET Company Participants Mike Booth – Head of Investor Relations Hervé Hoppenot – Chairman,...

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 9) Abbott ...

Biopharma stocks advanced in the week ended Feb. 5, driven higher by a slew of catalysts. Large-cap pharma earnings, vaccine updates, M&A acti...

Biopharma stocks advanced in the week ended Feb. 5, driven higher by a slew of catalysts. Large-cap pharma earnings, vaccine updates, M&A activity, IPO ...

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.36%

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 14) 10X ...